Overview
Amyotrophic lateral sclerosis (ALS) plus syndrome encompasses a broader spectrum of neurodegenerative conditions characterized by progressive motor neuron degeneration, often accompanied by additional neurological and systemic manifestations. Stakeholders, including patients, caregivers, and healthcare providers, frequently harbor misconceptions about palliative care, often conflating it with hospice care, which is limited to end-of-life comfort [PMID:32066316]. This misunderstanding can hinder timely integration of palliative care services, which are crucial for managing symptoms, improving quality of life, and addressing the multifaceted needs of ALS patients and their families. Palliative care in ALS should be viewed as an essential component of comprehensive management, starting early in the disease course and continuing throughout the patient's journey, regardless of disease progression stage.
Pathophysiology
The etiology of ALS remains multifaceted, with ongoing debates surrounding potential environmental and genetic factors. Vigorous physical activity, head trauma, and exposure to substances such as pesticides and nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed as contributing factors to ALS pathogenesis [PMID:28413696]. Epidemiological studies, particularly those focusing on populations with high levels of physical exertion or head injuries, such as athletes in contact sports, suggest a possible link between these factors and increased ALS risk. However, the literature presents mixed results; while some studies indicate a heightened risk associated with vigorous physical activity, others find no significant association or even protective effects [PMID:28413696]. These conflicting findings underscore the complexity of ALS etiology and the need for further research to elucidate definitive causal relationships.
Epidemiology
Epidemiological studies have shed light on various risk factors and trends in ALS incidence and management. A systematic investigation into sports-related factors among Swiss ALS patients highlighted the significance of contact sports and vigorous physical activity in potentially influencing ALS risk, alongside head trauma [PMID:28413696]. These findings suggest that clinicians should consider a patient’s history of physical activity and head injuries when assessing ALS risk and prognosis. Additionally, trends in healthcare utilization among ALS patients reveal a notable increase in the use of specialized palliative care services (sPCS) from 2010 to 2019, rising from 8.9% to 16.6% among hospitalized patients [PMID:38324041]. This trend indicates growing recognition of the importance of palliative care in managing ALS symptoms and improving patient outcomes across diverse populations.
Clinical Presentation
ALS presents with a wide array of symptoms that evolve over time, significantly impacting patients' daily lives. Common clinical manifestations include progressive muscle weakness, atrophy, and fasciculations, often accompanied by bulbar symptoms such as dysarthria, dysphagia, and sialorrhea [PMID:37203937]. A case study of a 45-year-old male with bulbar onset ALS illustrates acute respiratory distress secondary to recurrent aspiration pneumonitis, highlighting the critical nature of dysphagia management in ALS [PMID:37203937]. Beyond motor symptoms, patients frequently report significant non-motor symptoms including fatigue, pain, cognitive changes, depression, and anxiety, which profoundly affect quality of life [PMID:32396393]. These symptoms necessitate a holistic approach to care, addressing both physical and psychological well-being.
Patients with more severe disease, as indicated by lower ALS Functional Rating Scale-Revised (ALSFRS-R) scores, often exhibit younger age at onset, longer disease duration, reduced physical activity levels, and lower sun exposure, all factors associated with poorer nutritional status [PMID:26429656]. This underscores the importance of monitoring nutritional parameters and implementing tailored nutritional interventions early in the disease course to potentially slow disease progression and improve quality of life.
Diagnosis
Diagnosing ALS involves a comprehensive clinical evaluation, often supplemented by neuroimaging and electrophysiological studies, despite normal MRI findings of the brain and spinal cord in many cases [PMID:37203937]. Neurologists play a pivotal role in diagnosing ALS, particularly when cranial nerve involvement (9th, 10th, 11th, and 12th) is observed, which is characteristic of bulbar onset ALS [PMID:37203937]. Differential diagnosis must consider other motor neuron diseases and conditions that mimic ALS symptoms, such as spinal muscular atrophy, multifocal motor neuropathy, and certain parkinsonian syndromes. A thorough history, including potential head injuries, especially in former athletes, is crucial, as these factors may influence diagnostic considerations and management strategies [PMID:28413696].
Differential Diagnosis
In the differential diagnosis of ALS, clinicians must consider conditions that present with similar motor neuron degeneration symptoms, particularly those associated with a history of head trauma. Former athletes, especially those involved in contact sports like football and ice hockey, may warrant closer scrutiny due to the potential link between head injuries and ALS risk [PMID:28413696]. Other differential diagnoses include hereditary spastic paraplegias, primary lateral sclerosis, and certain metabolic myopathies. Comprehensive evaluation, including detailed patient history, neurological examination, and possibly genetic testing, is essential to rule out these conditions and confirm an ALS diagnosis.
Management
The management of ALS requires a multidisciplinary approach, integrating symptomatic treatment, supportive care, and palliative strategies to optimize quality of life. Symptomatic treatments include pharmacological interventions for common issues such as sialorrhea, where anticholinergic medications like atropine, hyoscyamine, and glycopyrrolate are often first-line therapies [PMID:26515628]. These medications can be administered intermittently or continuously via transdermal routes, depending on symptom severity and patient preference. A randomized controlled trial demonstrated significant improvement in sialorrhea with botulinum toxin type B (BTxB) injections into salivary glands, with 82% of patients reporting global improvement compared to 38% in the placebo group [PMID:26515628]. For refractory cases, low-dose radiation therapy to the salivary glands may be considered, though it comes with potential side effects such as erythema and nausea [PMID:26515628].
Palliative care integration is increasingly recognized as vital, with stakeholders emphasizing its role in addressing both physical and psychological symptoms [PMID:32066316]. Specialist palliative care teams are valued for their responsiveness to urgent needs, management of mood disorders, and handling of non-pain physical symptoms [PMID:40827427]. However, there is room for improvement, particularly in addressing spiritual and existential concerns and facilitating access to in-home care services, areas where satisfaction levels are notably lower [PMID:40827427]. Initiating palliative care early, ideally around 14.6 months post-diagnosis on average, can significantly enhance patient and caregiver well-being [PMID:40827427].
Innovative care models, such as home-based multidisciplinary teams comprising neurologists, palliative care physicians, nurses, social workers, and chaplains, have shown promising outcomes, including increased rates of home death and high patient satisfaction scores [PMID:39073146]. These models not only improve symptom management but also provide comprehensive support to caregivers, addressing their evolving needs throughout the disease trajectory [PMID:39073146]. Additionally, studies indicate that multidisciplinary care (MDC) can extend survival times, with a mean difference of 141.67 days compared to general neurological care [PMID:33443670]. Despite these benefits, disparities in care access persist, influenced by resource allocation biases and insurance barriers, necessitating policy adjustments to ensure equitable access to specialized support [PMID:26467979].
Complications
ALS patients face numerous complications that can significantly impact their quality of life and necessitate proactive management. Recurrent aspiration pneumonitis is a critical complication, often leading to multiple hospitalizations and necessitating interventions such as percutaneous endoscopic gastrostomy (PEG) tubes for feeding support [PMID:37203937]. Respiratory failure is another severe complication, frequently requiring interventions like tracheostomy and long-term mechanical ventilation to sustain life [PMID:37203937]. Nutritional decline, marked by lower Body Mass Index (BMI) and Geriatric Nutritional Risk Index (GNRI) scores, correlates strongly with disease severity and faster progression, underscoring the importance of tailored nutritional interventions [PMID:26429656]. Caregivers also experience substantial burdens, with approximately 35% reporting devastating financial impacts and 64% noting declines in their own health, highlighting the need for comprehensive support systems that address both patient and caregiver well-being [PMID:32396393].
Prognosis & Follow-up
The prognosis for ALS remains guarded, with progressive motor neuron degeneration leading to significant functional decline. Respiratory complications, such as the need for tracheostomy and mechanical ventilation, often signal advanced disease stages and poorer outcomes [PMID:37203937]. Nutritional status, as indicated by parameters like BMI and GNRI, serves as a prognostic indicator, with lower scores correlating with faster disease progression and poorer outcomes [PMID:26429656]. Advance care planning is increasingly integrated into ALS management, with palliative care teams facilitating discussions on goals of care, particularly around symptom management and end-of-life preferences [PMID:33533539]. Studies show that patients receiving multidisciplinary care exhibit longer survival times, emphasizing the clinical benefit of comprehensive support [PMID:33443670]. However, caregiver perspectives reveal higher stress levels and less perceived treatment efficacy compared to patients, underscoring the necessity for tailored support addressing both patient and caregiver needs throughout the disease course [PMID:32396393].
Special Populations
Former athletes, particularly those involved in contact sports with high incidences of head trauma, represent a distinct subgroup within ALS patients who may require specialized considerations [PMID:28413696]. These individuals often face unique challenges related to their athletic history, which can influence both the clinical presentation and management strategies. Caregivers of ALS patients also constitute a critical special population, experiencing significant emotional and physical strain. Support networks, including family members and community services, play a vital role in addressing the evolving needs of both patients and caregivers throughout the disease trajectory [PMID:26467979]. Bereavement support remains essential even after the patient's passing, as evidenced by the ongoing needs of caregivers (C-DPALS) [PMID:32396393]. Tailored psychological and social support services are crucial to mitigate the multifaceted impacts of ALS on these special populations.
Key Recommendations
References
1 Rai K, Rai N, Chhantel Thapa MK, Shrestha R, Singh S, Thapa M. Bulbar Onset Amyotrophic Lateral Sclerosis: A Case Report. JNMA; journal of the Nepal Medical Association 2023. link 2 Washington KT, Kukulka K, Govindarjan R, Mehr DR. Engaging Specialist Palliative Care in the Management of Amyotrophic Lateral Sclerosis: A Patient-, Family-, and Provider-Based Approach. Journal of palliative care 2022. link 3 Feddermann-Demont N, Junge A, Weber KP, Weller M, Dvořák J, Tarnutzer AA. Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients. Brain and behavior 2017. link 4 Jackson CE, McVey AL, Rudnicki S, Dimachkie MM, Barohn RJ. Symptom Management and End-of-Life Care in Amyotrophic Lateral Sclerosis. Neurologic clinics 2015. link 5 Mehta AK, Kojimoto G, O'Riordan DL, Leavell YL, Maiser S, Grouls A et al.. Patients' and Caregivers' Perceptions of Specialty Palliative Care for Amyotrophic Lateral Sclerosis: A Multicenter Evaluation. Muscle & nerve 2025. link 6 Bublitz SK, Eham M, Ellrott H, Littger B, Richter J, Lorenzl S. Homecare amyotrophic lateral sclerosis (ALS): A multidisciplinary, home-based model of care for patients with ALS and their caregivers. Muscle & nerve 2024. link 7 Harris CM, Higgins C, Mehta AK. Trends in Specialty Palliative Care Service Utilization and In-Hospital Outcomes for Patients With Amyotrophic Lateral Sclerosis. Journal of palliative medicine 2024. link 8 Hafer J, Jensen S, Wiedau-Pazos M, Mehta AK. Assessment of feasibility and utility of universal referral to specialty palliative care in a multidisciplinary amyotrophic lateral sclerosis clinic: A cohort study. Muscle & nerve 2021. link 9 de Almeida FEO, do Carmo Santana AK, de Carvalho FO. Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021. link 10 Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M et al.. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotrophic lateral sclerosis & frontotemporal degeneration 2020. link 11 Cappellato V, Bosco N, Chiò A, Calvo A. Curable or treatable? The implications of different definitions of illness when treating patients suffering from amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis & frontotemporal degeneration 2015. link 12 Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition (Burbank, Los Angeles County, Calif.) 2015. link 13 Centers LC. Beyond denial and despair: ALS and our heroic potential for hope. Journal of palliative care 2001. link 14 Bolmsjö I, Hermerén G. Interviews with patients, family, and caregivers in amyotrophic lateral sclerosis: comparing needs. Journal of palliative care 2001. link